<DOC>
	<DOCNO>NCT00847847</DOCNO>
	<brief_summary>Consistent data suggest neuromuscular transmission impaired ALS patient . Neuromuscular junction dysfunction may appear early disease , show data animal model . The pathogenesis neuromuscular transmission impairment unknown . Nogo A isoform , possible marker disease over-expressed skeletal muscle ALS patient , involve . We characterize pathophysiological mechanism implicate use complete study structure function NMJ muscle biopsy , group 20 ALS patient compare 10 control .</brief_summary>
	<brief_title>Neuromuscular Transmission Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Amyotrophic Lateral Sclerosis ( ALS ) progressive neurodegenerative disorder involve motor neuron motor cortex , brain stem spinal cord . Its pathogenesis remain unknown , drug currently available , riluzole , modestly prolong survival . Consistent data show neuromuscular transmission impair patient ALS . The significance abnormality remain unknown , recent data suggest potentially play key role pathogenesis disease . Neuromuscular junction ( NMJs ) dysfunction may appear early disease , show data animal model . The mechanisms neuromuscular transmission impairment unknown . Nogo A belonging family neurite outgrowth inhibitor protein abnormally express skeletal muscle ALS patient , probably involve show over-expression Nogo A wild-type muscle lead destabilization NMJs . A detailed study structure function NMJ ALS patient mandatory well characterize pathophysiological mechanism implicate . The aim study characterize neuromuscular transmission dysfunction ALS . For purpose , study structural functional feature NMJs muscle biopsy group 20 ALS patient compare 10 control . Using biopsy vestigial muscle , anconeus , perform morphological study NMJ , include routine histochemistry , immunohistochemical study NMJ major protein immune IgG complex electron microscopy study . The number acetylcholine receptor per endplate determine radiolabeled alpha-bungarotoxin binding . Expression level Nogo-A determine muscle specimen western blot . Synaptic transmission individual NMJs also study ex vivo . We record membrane potential time use different nerve stimulation frequency analyze property miniature endplate potential ( spontaneous release acetylcholine ) endplate potential stimulation nerve ( evoked release acetylcholine ) . The result structural functional study NMJ muscle biopsy correlate surface-EMG clinical data . This study help identify new mechanism involve pathophysiology ALS potential new target future treatment .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>1 . ALS patient : Inclusion criterion : Aged 18 75 ( inclusive ) Possible , probable ( clinically laboratory ) definite ALS accord revise El Escorial criterion Duration disease le 12 month Willing able provide write informed consent With french social insurance affiliation Exclusion criterion : Cognitive change psychiatric condition , inability give inform consent patient unable contact contact investigator case emergency woman pregnant nursing concomitant medication contraindicate muscular biopsy ( platelet suppressive agent treatment medically stop 2 week surgical procedure , oral anticoagulant therapy ) medical condition contraindicate muscular biopsy ( hypocoagulative disease , allergy anaesthetic drug ) medical condition susceptible influence EMG examination ( concomitant neurological rheumatological disease ) 2 . Controls : adult patient ( minimum 18y ) without neuromuscular disease undergo elbow surgery local joint bone disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>ALS</keyword>
	<keyword>Motor neuron</keyword>
	<keyword>Pathophysiology</keyword>
	<keyword>Neuromuscular junction</keyword>
	<keyword>Neuromuscular transmission</keyword>
	<keyword>Microelectrodes</keyword>
</DOC>